Osaka, Japan

Hiroshi Tokura

This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignee: Ono Pharmaceutical Co., Ltd.. Active years: 2019-2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hiroshi Tokura. Retrieved from https://idiyas.com/inventor/hiroshi-tokura

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0


Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 9(Granted Patents)


Company Filing History:


Years Active: 2019-2022

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovative Mind of Hiroshi Tokura

Introduction

Hiroshi Tokura, an accomplished inventor based in Osaka, Japan, is recognized for his contributions to the field of pharmaceuticals. With two registered patents to his name, Tokura has made significant advancements in drug development, particularly related to cancer treatment. His work reflects a commitment to leveraging innovation for the betterment of health.

Latest Patents

Among Hiroshi Tokura's latest patents is a BRK inhibitory compound. The invention involves a compound represented by a general formula (I), where all symbols correspond to those defined in the associated specification. This compound and its derivatives, including salts, solvates, N-oxides, or prodrugs, exhibit BRK inhibitory activity. This property makes the compound a valuable drug ingredient in the prevention and treatment of BRK-related diseases, such as cancer. His dedication to addressing critical health issues through innovative pharmaceutical solutions is evident in his research.

Career Highlights

Hiroshi Tokura is an integral part of Ono Pharmaceutical Co., Ltd., a company renowned for its focus on researching and developing effective therapies. His inventive approach has contributed to the company’s reputation in the pharmaceutical industry, particularly in creating compounds that play a vital role in treating serious diseases.

Collaborations

Token of his collaborative spirit, Hiroshi works alongside esteemed colleagues such as Shingo Yamamoto and Masakuni Kurono. Their combined expertise fosters an environment conducive to groundbreaking innovations in drug development, illustrating the power of teamwork in the journey of scientific discovery.

Conclusion

Hiroshi Tokura exemplifies the spirit of innovation in the pharmaceutical arena. His work on BRK inhibitory compounds underlines the potential of scientific advancements to address pressing health challenges. As he continues his research at Ono Pharmaceutical Co., Ltd., the contributions made by Tokura and his colleagues are poised to leave a lasting impact on healthcare, inspiring the next generation of inventors and innovators.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…